Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J Takes Leaner, But Stronger Business Approach With Management Consolidation

This article was originally published in The Pink Sheet Daily

Executive Summary

The health care giant is eliminating some management positions with more organizational announcements expected in coming weeks.

You may also be interested in...

J&J Wants Comparative Effectiveness Studies on Long-Acting Anti-Psychotics

The Institute of Medicine's report on CE priorities, to be released June 30, may shape agenda across a number of product categories.

J&J Pharma Presents a Robust Pipeline and Outlines A New R&D Structure

In a wide-ranging presentation to Wall Street, the company highlights key new products in development and an R&D strategy built around five therapeutic areas.

J&J Reorganizes Again; Scodari Announces Retirement, Poon Will Take Over

In its latest restructuring move, announced Nov. 15, Johnson & Johnson - a model for diversified health care companies - is focusing on providing integrated health solutions rather than individual products





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts